Zollinger-Ellison-Syndrome-Market-Insights

DelveInsigth’s Zollinger-Ellison Syndrome market report provides an in-depth understanding of the Zollinger-Ellison Syndrome, historical and forecasted epidemiology, as well as Zollinger-Ellison Syndrome market trends in the 7MM (the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan). 

Some of the Key Highlights from the Zollinger-Ellison Syndrome Market Report

  • According to NIDDK, Zollinger-Ellison Syndrome is extremely rare. It affects one in a million people globally. It is more common in men than in women and usually occurs between the ages of 30 and 50.
  • In the United States, approximately 0.1-1 percent of all patients with duodenal ulcers have Zollinger-Ellison Syndrome (ZES).
  • Key players such as Phathom Pharmaceuticals and others are diligently working toward the development of novel therapies for Zollinger-Ellison Treatment.
  • Vonoprazan (Phathom Pharmaceuticals), is a late-stage investigational potassium competitive acid blocker (P-CAB) for the treatment of gastric acid-related disorders. 

For a better understanding of the disease, request sample @ Zollinger-Ellison Syndrome Symptoms, Diagnosis and Therapy

The Zollinger-Ellison Syndrome market report covers current treatment practices, emerging drugs, Zollinger-Ellison Syndrome market share of individual therapies, as well as current and forecasted Zollinger-Ellison Syndrome market Size from 2018 to 2030, segmented by seven major markets.

Zollinger-Ellison Syndrome: Overview

The Zollinger-Ellison Syndrome (ZES) is characterized by the development of a tumor (gastrinoma) or tumors that secrete excessive amounts of gastrin, a hormone that stimulates the stomach’s acid production. Many people who are affected develop multiple gastrinomas, which are thought to be cancerous (malignant). The majority of patients’ tumors develop in the pancreas and/or the upper region of the small intestine (duodenum). Individuals with ZES may develop peptic ulcers of the stomach, duodenum, and/or other regions of the digestive tract as a result of excessive acid production (gastric acid hypersecretion).

Zollinger-Ellison Syndrome Epidemiology Segmentation

The Zollinger-Ellison Syndrome report proffers epidemiological analysis for the study period 2018-30 in the 7MM segmented into:

  • Zollinger-Ellison Syndrome Incident Cases
  • Zollinger-Ellison Syndrome Gender-Specific Cases
  • Zollinger-Ellison Syndrome Age-Specific Cases
  • Zollinger-Ellison Syndrome Diagnosed and Treated Cases

Get the complete epidemiology analysis @ Zollinger-Ellison Syndrome Risk Factors

Zollinger-Ellison Syndrome Treatment Landscape

The Zollinger-Ellison syndrome (ZES) treatment goals are medical control of gastric acid hypersecretion and surgical resection of the tumor. Proton Pump Inhibitors (PPIs) drugs that are used to reduce stomach acid production and allow ulcers to heal include lansoprazole (Prevacid), omeprazole (Prilosec, Zegerid), pantoprazole (Protonix), dexlansoprazole (Dexilant), esomeprazole (Nexium), and rabeprazole (Aciphex). For patients with advanced cancer, a combination of therapies such as surgery, chemotherapy, Octreotide (Sandostatin), targeted drug therapy, or radiation may be beneficial.

Zollinger-Ellison Syndrome Market 

Extensive research and development activities by pharmaceutical companies such as Phathom Pharmaceuticals, as well as the anticipated launch of approved therapies such as Vonoprazan and others will drive Zollinger-Ellison Syndrome market growth during the forecast period, i.e., 2021–2030.

Zollinger-Ellison Syndrome Pipeline Therapies and Key Companies 

  • Vonoprazan: Phathom Pharmaceuticals

For further information on the emerging drugs, visit Zollinger-Ellison Syndrome Treatment Drugs

Table of Contents 

1. Key Insights
2. Zollinger-Ellison Syndrome (ZES) Market Overview at a Glance
3. Executive summary
4. Organizations
5. Disease Overview: Zollinger-Ellison Syndrome (ZES)
6. Zollinger-Ellison Syndrome Epidemiology and Patient Population
7. Zollinger-Ellison Syndrome Current Treatment Practices
8. Zollinger-Ellison Syndrome Unmet Needs
9. Zollinger-Ellison Syndrome Marketed Drugs
10. Zollinger-Ellison Syndrome Emerging Therapies
11. Zollinger-Ellison Syndrome (ZES): 7MM Analysis
12. Zollinger-Ellison Syndrome Market Drivers
13. Zollinger-Ellison Syndrome Market Barriers
14. Zollinger-Ellison Syndrome Market Access and Reimbursement
15. SWOT Analysis
16. Case studies
17. KOL Views
18. Appendix
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
22. Disclaimer

Know more about report offerings @ Zollinger-Ellison Syndrome Market Size

Related Reports

Alagille Syndrome Market

Get comprehensive historical and forecast analysis of Alagille Syndrome Market, Epidemiological and Therapeutics market domain with a special focus on key companies such as Mirum Pharmaceuticals, Albireo, among others.

Fragile X Syndrome Market

Get comprehensive historical and forecast analysis of Fragile X Syndrome Market, Epidemiological and Therapeutics market domain with a special focus on key companies such as Neuren Pharmaceuticals, Ovid Therapeutics, Tetra Therapeutics,  Confluence Pharmaceuticals, Zynerba Pharmaceuticals, among others.

Metastatic Bone Pain Market

DelveInsight’s “Metastatic Bone Pain – Market Insights, Epidemiology, and Market Forecast-2030” report.

Metastatic Melanoma Market

DelveInsight’s “Metastatic Melanoma – Market Insights, Epidemiology, and Market Forecast-2030” report.

Alport Syndrome Market

DelveInsight’s “Alport Syndrome – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Alport Syndrome, historical and forecasted epidemiology as well as the Alport Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Acute Myeloid Leukemia Market 

Get comprehensive historical and forecast analysis of Acute Myeloid Leukemia Market, Epidemiological and Therapeutics market domain with a special focus on key companies such as Pfizer, Abbvie, Astellas Pharma, among others.

Multiple Myeloma Market

Get comprehensive historical and forecast analysis of Multiple Myeloma Market, Epidemiological and Therapeutics market domain with a special focus on key companies such as Johnson & Johnson, Amgen,  BioLineRx, Bristol-Myers Squibb, ExCellThera, Pfizer,  Takeda, Precision BioSciences,  Poseida Therapeutics, among others.

Friedreich’s Ataxia Market

DelveInsight’s “Friedreich’s Ataxia – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Friedreich’s Ataxia, historical and forecasted epidemiology as well as the Friedreich’s Ataxia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Metastatic Colorectal Cancer Market

Get comprehensive historical and forecast analysis of Metastatic Colorectal Cancer Market, Epidemiological and Therapeutics market domain with a special focus on key companies such as Merck, Eli Lilly, Bristol-Myers Squibb, Amgen, Taiho Oncology, Pfizer, Isofol Medical, Ab Science, Effector Therapeutics, Vaximm, Cardiff Oncology, others.

Dravet Syndrome Market 

Get comprehensive historical and forecast analysis of Dravet Syndrome Market, Epidemiological and Therapeutics market domain with a special focus on key companies such as Biocodex, GW Pharmaceuticals, Zogenix, Ovid Therapeutics, PTC Therapeutics, among others.

For rich insights into Healthcare and Pharmaceutical News, visit Pharma, Healthcare, and Biotech Blog Posts

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance. 

Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

Contact Us 

Sandeep Joshi 

[email protected] 

+1(919)321-6187 

www.delveinsight.com

Connect With Us at:

LinkedIn | Facebook | Twitter

Tags: Zollinger-Ellison Syndrome Risk Factors, Zollinger- Ellison Syndrome Casuses, Zollinger-Ellison Syndrome Treatment Drug, Zollinger-Ellison Syndrome, Zollinger-Ellison Syndrome Symptoms, Zollinger-Ellison Syndrome Diagnostic Tests, Zollinger-Ellison Syndrome Market Size

Contact Information:

Sandeep Joshi 

[email protected] 

+1(919)321-6187